Clinical trials
Proteinuria trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| AstraZeneca | 3 |
| Bayer | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Federal University of Pelotas | 1 |
| University of Campinas, Brazil | 1 |
| University of Sao Paulo | 1 |
| University of Sao Paulo General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Proteinuria | 15 |
| Renal Insufficiency, Chronic | 6 |
| Diabetes Mellitus | 3 |
| Diabetic Nephropathies | 3 |
| Glomerulonephritis, IGA | 3 |
| Hyperlipidemias | 2 |
| Hypertension | 2 |
| Cardiovascular Diseases | 1 |
| Disease Progression | 1 |
| Lupus Erythematosus, Systemic | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.